FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2398545285> ?p ?o ?g. }

• W2398545285 abstract "To determine in a large claims database the healthcare utilization and costs associated with treatment of alcohol dependence with medications vs no medication and across 4 US Food and Drug Administration (FDA)-approved medications.Claims database analysis.Eligible adults with alcohol dependence claims (n = 27,135) were identified in a commercial database (MarketScan; Thomson Reuters Inc, Chicago, Illinois). Following propensity score-based matching and inverse probability weighting on demographic, clinical, and healthcare utilization variables, patients who had used an FDA-approved medication for alcohol dependence (n = 2977)were compared with patients who had not (n =2977). Patients treated with oral naltrexone hydrochloride(n = 2064), oral disulfiram (n = 2076), oral acamprosate calcium (n = 5068), or extended-release injectable naltrexone (naltrexone XR) (n = 295) were also compared for 6-month utilization rates of alcoholism medication, inpatient detoxification days, alcoholism-related inpatient days, and outpatient services, as well as inpatient charges.Patients who received alcoholism medications had fewer inpatient detoxification days (706 vs 1163 days per 1000 patients, P <.001), alcoholism-related inpatient days (650 vs 1086 days, P <.001), and alcoholism-related emergency department visits (127 vs 171, P = .005). Among 4 medications, the use of naltrexone XR was associated with fewer inpatient detoxification days (224 days per 1000 patients) than the use of oral naltrexone (552 days, P = .001), disulfiram (403 days, P = .049), or acamprosate (525 days, P <.001). The group receiving naltrexone XR also had fewer alcoholism-related inpatient days than the groups receiving disulfiram or acamprosate. More patients in the naltrexone XR group had an outpatient substance abuse visit compared with patients in the oral alcoholism medication groups.Patients who received an alcoholism medication had lower healthcare utilization than patients who did not. Naltrexone XR showed an advantage over oral medications in healthcare utilization and costs." @default.
• W2398545285 created "2016-06-24" @default.
• W2398545285 creator A5001794876 @default.
• W2398545285 creator A5015054723 @default.
• W2398545285 creator A5038414404 @default.
• W2398545285 creator A5059037972 @default.
• W2398545285 creator A5075961872 @default.
• W2398545285 date "2010-01-01" @default.
• W2398545285 modified "2023-09-23" @default.
• W2398545285 title "Comparison of healthcare utilization among patients treated with alcoholism medications." @default.
• W2398545285 cites W1553583298 @default.
• W2398545285 cites W1973869640 @default.
• W2398545285 cites W1983857792 @default.
• W2398545285 cites W2022881140 @default.
• W2398545285 cites W2039993999 @default.
• W2398545285 cites W2042353763 @default.
• W2398545285 cites W2043239339 @default.
• W2398545285 cites W2054992104 @default.
• W2398545285 cites W2062285900 @default.
• W2398545285 cites W2063443884 @default.
• W2398545285 cites W2066059923 @default.
• W2398545285 cites W2067227935 @default.
• W2398545285 cites W2086175717 @default.
• W2398545285 cites W2086730289 @default.
• W2398545285 cites W2087081361 @default.
• W2398545285 cites W2101372918 @default.
• W2398545285 cites W2123760900 @default.
• W2398545285 cites W2136636673 @default.
• W2398545285 cites W2138742021 @default.
• W2398545285 cites W2139226057 @default.
• W2398545285 cites W2169755310 @default.
• W2398545285 cites W2416444369 @default.
• W2398545285 cites W2155959339 @default.
• W2398545285 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4160801" @default.
• W2398545285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21348558" @default.
• W2398545285 hasPublicationYear "2010" @default.
• W2398545285 type Work @default.
• W2398545285 sameAs 2398545285 @default.
• W2398545285 citedByCount "13" @default.
• W2398545285 countsByYear W23985452852013 @default.
• W2398545285 countsByYear W23985452852014 @default.
• W2398545285 countsByYear W23985452852015 @default.
• W2398545285 countsByYear W23985452852017 @default.
• W2398545285 countsByYear W23985452852019 @default.
• W2398545285 countsByYear W23985452852020 @default.
• W2398545285 countsByYear W23985452852023 @default.
• W2398545285 crossrefType "journal-article" @default.
• W2398545285 hasAuthorship W2398545285A5001794876 @default.
• W2398545285 hasAuthorship W2398545285A5015054723 @default.
• W2398545285 hasAuthorship W2398545285A5038414404 @default.
• W2398545285 hasAuthorship W2398545285A5059037972 @default.
• W2398545285 hasAuthorship W2398545285A5075961872 @default.
• W2398545285 hasConcept C118552586 @default.
• W2398545285 hasConcept C126322002 @default.
• W2398545285 hasConcept C150966472 @default.
• W2398545285 hasConcept C168563851 @default.
• W2398545285 hasConcept C170493617 @default.
• W2398545285 hasConcept C185592680 @default.
• W2398545285 hasConcept C197934379 @default.
• W2398545285 hasConcept C2777972943 @default.
• W2398545285 hasConcept C2778523461 @default.
• W2398545285 hasConcept C2779436514 @default.
• W2398545285 hasConcept C2779442783 @default.
• W2398545285 hasConcept C2779992327 @default.
• W2398545285 hasConcept C2780931562 @default.
• W2398545285 hasConcept C2781063702 @default.
• W2398545285 hasConcept C2781066024 @default.
• W2398545285 hasConcept C2908647359 @default.
• W2398545285 hasConcept C55493867 @default.
• W2398545285 hasConcept C71924100 @default.
• W2398545285 hasConcept C98274493 @default.
• W2398545285 hasConcept C99454951 @default.
• W2398545285 hasConceptScore W2398545285C118552586 @default.
• W2398545285 hasConceptScore W2398545285C126322002 @default.
• W2398545285 hasConceptScore W2398545285C150966472 @default.
• W2398545285 hasConceptScore W2398545285C168563851 @default.
• W2398545285 hasConceptScore W2398545285C170493617 @default.
• W2398545285 hasConceptScore W2398545285C185592680 @default.
• W2398545285 hasConceptScore W2398545285C197934379 @default.
• W2398545285 hasConceptScore W2398545285C2777972943 @default.
• W2398545285 hasConceptScore W2398545285C2778523461 @default.
• W2398545285 hasConceptScore W2398545285C2779436514 @default.
• W2398545285 hasConceptScore W2398545285C2779442783 @default.
• W2398545285 hasConceptScore W2398545285C2779992327 @default.
• W2398545285 hasConceptScore W2398545285C2780931562 @default.
• W2398545285 hasConceptScore W2398545285C2781063702 @default.
• W2398545285 hasConceptScore W2398545285C2781066024 @default.
• W2398545285 hasConceptScore W2398545285C2908647359 @default.
• W2398545285 hasConceptScore W2398545285C55493867 @default.
• W2398545285 hasConceptScore W2398545285C71924100 @default.
• W2398545285 hasConceptScore W2398545285C98274493 @default.
• W2398545285 hasConceptScore W2398545285C99454951 @default.
• W2398545285 hasLocation W23985452851 @default.
• W2398545285 hasOpenAccess W2398545285 @default.
• W2398545285 hasPrimaryLocation W23985452851 @default.
• W2398545285 hasRelatedWork W1546520989 @default.
• W2398545285 hasRelatedWork W1635084872 @default.
• W2398545285 hasRelatedWork W1918759949 @default.
• W2398545285 hasRelatedWork W2022881140 @default.
• W2398545285 hasRelatedWork W2029498480 @default.

• next